Dr. Moshe Gatt is the director of the Hematology department at the Hadassah Hebrew University Medical Center, Jerusalem. He is also a senior lecturer of hematology. His interest is in monoclonal gammopathies, multiple myeloma and AL amyloidosis in particular.

Dr. Gatt received his medical degree from the Hebrew University School of Medicine. He then completed his residencies and fellowships at the Hadassah Medical Center, Jerusalem, Israel, and did a research fellowship at the Jerome Lipper center for Multiple Myeloma, Department of Medical Oncology, Dana Farber Medical Center and Harvard Medical school, Boston, MA. USA.

His research interests include plasma cell dyscrasias, multiple myeloma and amyloidosis. Dr. Gatt’s work revolves around improving current diagnostic techniques for AL amyloidosis and in investigating novel methods to study this disease. He has also investigated and reported various treatments outcomes in MM, and is participating in many phase 2 and 3 clinical trials in Multiple Myeloma and Amyloidosis as a Principal Investigator or Sub-Investigator. He is an author of over 50 peer-reviewed publications in international journals.

He has been the secretary (2012-2016) and is currently the chairman of the Israeli Multiple Myeloma Study Group.